MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo
Liwei Ni, Jianhao Xu, Fenglun Zhao, Xiaoxiao Dai, Jialong Tao, Jie Pan, Aiming Shi, Zhu Shen, Cunjin Su, Yusong Zhang
Topics & Concepts
PaclitaxelMdm2A549 cellmicroRNACancer researchDownregulation and upregulationLung cancerIn vivoCell cultureBiologyCancerDrug resistanceMedicineOncologyGeneBiochemistryGeneticsMicrobiologyBiotechnologyMicroRNA in disease regulationCancer-related molecular mechanisms researchRNA modifications and cancer